Article info

Original research
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Authors

  1. Correspondence to Dr Georgia M Beasley; georgia.beasley{at}duke.edu
View Full Text

Citation

Beasley GM, Nair SK, Farrow NE, et al
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma

Publication history

  • Accepted March 14, 2021
  • First published April 19, 2021.
Online issue publication 
April 19, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.